secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tvardi Therapeutics, Inc. (TVRD)
CIK:        0001346830
Form:       8-K
Filed at:   2025-06-09T23:59:59+00:00
Accession:  0001104659-25-057524
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tvardi Therapeutics posts updated corporate presentation; no specific new data disclosed in filing
--------------------------------------------------------------------------------

- Company updated corporate presentation and posted it on investor relations website as of June 6, 2025.
- Presentation may be used in conversations with analysts and investors; no material financial or operational updates provided.
- Exhibit 99.1 content not fully available in this filing; no new guidance, trial results, or business developments detailed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1346830/000110465925057524/0001104659-25-057524-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1346830/000110465925057524/tm2517442d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-057524

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer